Literature DB >> 3719696

Regulated expression of human A gamma-, beta-, and hybrid gamma beta-globin genes in transgenic mice: manipulation of the developmental expression patterns.

G Kollias, N Wrighton, J Hurst, F Grosveld.   

Abstract

We have introduced the human fetal gamma- and adult beta-globin genes into the germ line of mice. Analysis of the resulting transgenic mice shows that the human gamma-globin gene is expressed like an embryonic mouse globin gene; the human beta-globin gene is expressed (as previously shown) like an adult mouse globin gene. These results imply that the regulatory signals for tissue- and developmental stage-specific expression of the globin genes have been conserved between man and mouse but that the timing of the signals has changed. Because the two genes are expressed differently, we introduced a hybrid gamma beta-globin gene construct. The combination of the regulatory sequences resulted in the expression of the hybrid gene at all stages in all the murine erythroid tissues.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3719696     DOI: 10.1016/0092-8674(86)90862-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  113 in total

1.  The polyoma virus enhancer cannot substitute for DNase I core hypersensitive sites 2-4 in the human beta-globin LCR.

Authors:  K Tanimoto; Q Liu; J Bungert; J D Engel
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

2.  The role of the -50 region of the human gamma-globin gene in switching.

Authors:  M S Ristaldi; D Drabek; J Gribnau; D Poddie; N Yannoutsous; A Cao; F Grosveld; A M Imam
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

Review 3.  Locus control regions.

Authors:  Qiliang Li; Kenneth R Peterson; Xiangdong Fang; George Stamatoyannopoulos
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

4.  Beta-globin locus activation regions: conservation of organization, structure, and function.

Authors:  Q L Li; B Zhou; P Powers; T Enver; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 5.  The regulatory network controlling beta-globin gene switching.

Authors:  W Shen; D P Liu; C C Liang
Journal:  Mol Biol Rep       Date:  2001       Impact factor: 2.316

6.  Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.

Authors:  D Murphy; A Bishop; G Rindi; M N Murphy; G W Stamp; J Hanson; J M Polak; B Hogan
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

7.  Beta-globin enhancers target expression of a heterologous gene to erythroid tissues of transgenic mice.

Authors:  J Magram; K Niederreither; F Costantini
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

Authors:  L Probert; K Akassoglou; M Pasparakis; G Kontogeorgos; G Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  Human G gamma and A gamma globin gene constructs containing the 3' A gamma enhancer show persistent fetal expression in transgenic mice.

Authors:  M P Harvey; J Crosbie; R J Trent
Journal:  Transgenic Res       Date:  1993-03       Impact factor: 2.788

10.  Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery.

Authors:  J C Plumier; B M Ross; R W Currie; C E Angelidis; H Kazlaris; G Kollias; G N Pagoulatos
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.